Femasys (FEMY) Debt to Equity (2020)

Femasys (FEMY) reported Debt to Equity of -$0.0 for Q4 2020.

Femasys (FEMY) Debt to Equity (2020) Analysis & Trends

Femasys has reported Debt to Equity for 1 years, with the latest figure at -$0.0 in Q4 2020.

For the quarter ending Q4 2020, Debt to Equity changed N/A year-over-year to -$0.0; the trailing twelve-month figure through Dec 2020 stood at -$0.0 (changed N/A YoY), and the FY2020 full-year result was -$0.0, changed N/A from the prior year.
Debt to Equity for Q4 2020 stood at -$0.0.
The five-year high for Debt to Equity was -$0.0 in Q4 2020, with the low at -$0.0 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.72
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	1.12
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.04
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.07
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	1.02
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.30
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	1.57
10	Femasys	254.59 Mn	249.20 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	0.00